BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kerachian MA, Azghandi M, Mozaffari-Jovin S, Thierry AR. Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA. Clin Epigenetics 2021;13:193. [PMID: 34663458 DOI: 10.1186/s13148-021-01182-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Fonseca A, Lobo J, Hazard FK, Gell J, Nicholls PK, Weiss RS, Klosterkemper L, Volchenboum SL, Nicholson JC, Frazier AL, Amatruda JF, Bagrodia A, Lockley M, Murray MJ. Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium. Br J Cancer 2022. [PMID: 36229581 DOI: 10.1038/s41416-022-02000-4] [Reference Citation Analysis]
2 Cox DR, Wong BKL, Lee E, Testro A, Muralidharan V, Dobrovic A, Goh SK. Evaluating DNA recovery efficiency following bisulphite modification from plasma samples submitted for cell-free DNA methylation analysis. Epigenetics 2022;:1-5. [PMID: 35763697 DOI: 10.1080/15592294.2022.2091821] [Reference Citation Analysis]
3 Krasic J, Skara L, Bojanac AK, Ulamec M, Jezek D, Kulis T, Sincic N. The utility of cfDNA in TGCT patient management: a systematic review. Ther Adv Med Oncol 2022;14:175883592210903. [DOI: 10.1177/17588359221090365] [Reference Citation Analysis]
4 Søiland H, Janssen EAM, Helland T, Eliassen FM, Hagland M, Nordgård O, Lunde S, Lende TH, Sagen JV, Tjensvoll K, Gilje B, Jonsdottir K, Gudlaugsson E, Lode K, Hagen KB, Gripsrud BH, Lind R, Heie A, Aas T, Austdal M, Egeland NG, Bernklev T, Lash TL, Skartveit L, Kroksveen AC, Oltedal S, Kvaløy JT, Lien EA, Sleire L, Mellgren G; PBCB-study group. Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study. BMJ Open 2022;12:e054404. [PMID: 35487718 DOI: 10.1136/bmjopen-2021-054404] [Reference Citation Analysis]
5 Mettler E, Fottner C, Bakhshandeh N, Trenkler A, Kuchen R, Weber MM. Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias. Cancers 2022;14:1025. [DOI: 10.3390/cancers14041025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kim Y, Lee BB, Kim D, Um SW, Han J, Shim YM, Kim DH. Aberrant Methylation of SLIT2 Gene in Plasma Cell-Free DNA of Non-Small Cell Lung Cancer Patients. Cancers (Basel) 2022;14:296. [PMID: 35053460 DOI: 10.3390/cancers14020296] [Reference Citation Analysis]
7 Zhou X, Zheng H, Fu H, Dillehay Mckillip KL, Pinney SM, Liu Y. CRAG: De novo characterization of cell-free DNA fragmentation hotspots in plasma whole-genome sequencing.. [DOI: 10.1101/2020.07.16.201350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]